Aggressive Angiomyxoma in the Anus of Elderly Male Authors: Shigeyuki Kosaka, Takahisa Hirokawa, Tatsuya Kawai, Hajime Ushigome, Takuya Suzuki, Yushi Yamakawa, Hiroki Takahashi, Yoichi Matsuo, Shuji Takiguchi Published: 2026 ABSTRACT AbstractAggressive angiomyxoma (AAM) is a rare mesenchymal tumor characterized by local invasion and a high recurrence rate, primarily affecting the pelvic-perineal region in women. It is extremely rare in men. Although male-onset cases are typically reported in the scrotum or buttocks, there have been no previously reported cases involving the anus. We report the first such case in a 71-year-old man initially diagnosed with prolapsed internal hemorrhoids (Goligher grade IV). The patient underwent surgical treatment; however, histological analysis of the specimen unexpectedly revealed AAM, with positive findings for CD34 (+), desmin (+), and partially positive ER (ER [partial +]). The postoperative course was complicated by hemorrhage, requiring hemostasis via vascular embolization. Despite the high recurrence rate of AAM, the patient has remained disease-free for over five years. Keywords: aggressive angiomyxoma, anus, male, postoperative bleeding, vascular embolization Introduction Aggressive angiomyxoma (AAM) is a rare stromal tumor. AAM has a predilection for the genital, perineal, and pelvic regions in young women. It is a benign tumor, histologically characterized by prominent angiogenesis, local invasion, and frequent local recurrence. This type of tumor was first reported in 1983 by Steeper and Rosai, in a case series of nine female patients[1]. The histological features of AAM include proliferation of small- and large-diameter blood vessels, and small, spindle-shaped or stellate cells with minimal atypia or division in the myxoid lipomatous stroma[2]. We present a rare case of aggressive angiomyxoma arising in the anus of an elderly man and discuss the diagnostic and therapeutic modalities. Case Report The patient was a 71-year-old man with a history of brain infarction and paralysis on the right side of the body. He had been aware of his anal tumor and rectal prolapse for more than 40 years, both of which he had manually reduced. He was hospitalized for a stroke, and it became increasingly difficult to reduce the anal tumors and rectal prolapse. Although manual reduction was still possible, the patient experienced frequent recurrences, and resection was performed. On physical examination, two masses measuring approximately 10 cm were noted: one at the 3 o'clock position and the other at the 7 o'clock position (Figure 1). Contrast-enhanced abdominal computed tomography (CT) demonstrated a 75 × 66 × 110 mm mass extending from the anus to the lower rectum with heterogeneous contrast enhancement (Figure 2). The patient underwent surgical resection using a semiclosed procedure, with preservation of the anal sphincter muscles. The tumor was elastic-hard, and its texture was consistent with giant internal hemorrhoids. The excised specimens measured 90 mm × 60 mm × 60 mm on the right side and 75 mm × 50 mm × 50 mm on the left side (Figure 3). During the postoperative course, due to hemorrhage, the patient underwent two hemostatic procedures and vascular embolization. Following the first hemorrhage on postoperative day (POD)8, hemostatic procedures and transfusion of 2 units of red blood cell concentrates (RCC) were performed. On POD11, hemostatic procedures were repeated, along with transfusion of 10 units of RCC and 4 units of fresh frozen plasma (FFP). On POD12, vascular embolization revealed multiple abnormal neovascularizations (Figure 4). By POD21, hemostasis was confirmed, and the patient was discharged on POD33. A 71-year-old man with a mass in the anus that slowly enlarged over 40 years. Transaxial and sagittal contrast-enhanced CT images showing a 75 × 66 × 110 mm heterogeneously enhancing mass extending from the anus. Macroscopic view of the excised specimens showing two masses: 90 × 60 × 60 mm (right side) and 75 × 50 × 50 mm (left side). (A) Schematic illustration showing the resection lines for the semiclosed procedure. (B) Intraoperative appearance before (C1) /after (C2) resection, showing a mass. Multiple abnormal vessels in the peripheral superior rectal artery (SRA) branches were detected, and vascular embolization was performed. Contrast-enhanced CT images before (A) and after (B) arterial embolization, showing the control of neovascularization. Histopathological analysis of the operative specimen revealed spindle-shaped cells growing in the background of the myxomatous stroma. In both specimens, the spindle-shaped cells extended to the resection margins. The findings― CD34 (+), SMA (−), Desmin (+), S-100 (−), β-catenin (−), and ER (partial +)―led to the diagnosis of AAM (Figure 5). After discharge, follow-up blood tests and contrast-enhanced whole body CT scans were performed every six months. Currently, there is no evidence of recurrence five years after resection. A microphotograph showing a spindle-shaped cell in a background of myxomatous stroma. Pathological features include CD34 (+), SMA (−), Desmin (+), S-100 (−), β-catenin (−), ER (partial +). This study was approved by the Institutional Review Board of Nagoya City University School of Medical Sciences (Approval Code: 60-19-0150). Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. Discussion Aggressive angiomyxoma (AAM) is a rare condition that commonly occurs in the pelvic and perineal regions in young women[1,3]. It occurs between ages 10-70, with a peak incidence at 31-35 years, and a male-to-female ratio of 1:6.6[2,3]. It is characterized by angiogenesis, local invasiveness, recurrence, and slow growth[2,4]. Pathological features include spindle- or stellate-shaped tumor cells and blood vessels of varying calibers. Immunohistochemical markers such as desmin, smooth muscle actin, muscle-specific actin, vimentin, ER, and PR are often positive; CD34 is occasionally positive, and S-100 protein is typically negative[3,5,6]. The frequent positivity of ER and PR may partly explain the difference in incidence between sexes. Further research is needed to fully understand these hormonal influences. According to a systematic review of male-onset AAM, approximately 50% of the cases tested positive for ER and PR[7]. In this rare case of AAM arising in the anal region of an elderly man, the diagnosis was established following the resection of a lesion initially suspected to be a Goligher grade IV internal hemorrhoid. The patient had been aware of the anal mass for over 40 years. While 40 years is an exceptionally long time, we suspect that the AAM had been present and grown very slowly throughout this entire period. Although the coexistence of benign internal hemorrhoids cannot be entirely ruled out, the slow-growing nature characteristic of AAMs is consistent with such a prolonged clinical course. The immunohistochemical profile (CD34+, SMA−, Desmin+, S-100−, β-catenin−, ER partial +) was consistent with AAM. A literature review reveals numerous reported cases of AAM in males, with the scrotum and buttocks being the most frequent locations[7-9]. However, primary occurrence in the anus appears to be extremely rare―even among females, to our knowledge. Complete surgical excision is the primary treatment for AAM[10,11]. However, owing to its local invasiveness, achieving negative surgical margins is challenging and often results in a high rate of local recurrence[3,4,10]. Although distant metastases are rare, long-term follow-up is crucial[12]. In this case, despite the potential for incomplete microscopic resection due to AAM's locally invasive nature, the patient remained recurrence-free for five years postoperatively. This unusually long disease-free interval warrants further investigation. Although embolization was performed primarily for hemostasis, multiple abnormal neovascularizations were identified, suggesting they were tumor-feeding vessels. This suggests that embolization of these tumor-feeding vessels may contribute to local recurrence control. This outcome implies potential control of residual tumor, even if unintentional. Han-Geurts et al. reported that multimodality treatments, including embolization, can effectively manage residual disease and help avoid radical surgery[13]. Embolization may contribute to local control in selected recurrent cases; however, evidence remains limited and outcomes are variable. This is particularly noteworthy, given AAM's local invasiveness and high recurrence rates[1,2]. Preoperative diagnosis of AAM remains challenging due to its rarity and nonspecific clinical and radiological features[14,15]. The unusual location in an elderly man further complicated the diagnostic process in this case. Differential diagnoses for AAM include tumors arising in the pelvis and perineum, particularly angiomyofibromatosis (AMFB) and desmoid-type fibromatosis. AMFB is typically a well-circumscribed, smaller mass. Histologically, it shows higher cellularity and lacks prominent thick-walled vessels. Desmoid-type fibromatosis can be reliably distinguished by its characteristic nuclear expression of β-catenin, which was negative in our patient. Furthermore, the absence of S-100 and SMA in our case effectively excluded other potential mimics, such as nerve sheath tumors and myogenic neoplasms. Successful management of postoperative hemorrhage with endovascular embolization highlights its potential utility in similar scenarios. However, the long-term efficacy of postoperative embolization in preventing recurrence requires further investigation. The five-year recurrence-free survival in this case, although encouraging, necessitates continued long-term follow-up to fully assess the treatment impact and overall prognosis of AAM in such rare presentations. Given the potential for recurrence, we consider that an indefinite follow-up period is necessary, with contrast-enhanced whole body CT performed every six months. Contributions to the submitted work from each author SK, TH and TK were engaged in the treatment of this patient. SK wrote the manuscript and created the photographs and figures, whereas TH reviewed and revised the manuscript. HU, TS, YY, HT, YM and ST supervised clinical practice. All authors have reviewed and approved the final manuscript. Approval code issued by the institutional review board (IRB) and the name of the institution(s) that granted the approval This study was approved by the Institutional Review Board of Nagoya City University School of Medical Sciences (Approval Code: 60-19-0150). COI The authors declare that there are no conflicts of interest References